MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹6.31 Cr | ₹29 Cr | ₹4.30 Cr | ₹5.84 Cr | ₹19 Cr |
What is the latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹6.31 Cr |
Mar2023 | ₹29 Cr |
Mar2022 | ₹4.30 Cr |
Mar2021 | ₹5.84 Cr |
Mar2020 | ₹19 Cr |
How is Cash Flow from Financing Activities of MEDICAMEN BIOTECH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹6.31 Cr | -78.32 | |
Mar2023 | ₹29 Cr | 577.69 | |
Mar2022 | ₹4.30 Cr | -26.39 | |
Mar2021 | ₹5.84 Cr | -69.37 | |
Mar2020 | ₹19 Cr | - |
Compare Cash Flow from Financing Activities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹582.4 Cr | -2.2% | -13.4% | -23.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹436,379.0 Cr | 0.8% | 7.2% | 22.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,420.0 Cr | 0.7% | 11% | 53.3% | Stock Analytics | |
CIPLA | ₹122,010.0 Cr | -2% | 4.6% | 10.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,634.0 Cr | -1.6% | 2.8% | 24.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,788.5 Cr | -1.4% | 0.7% | -5.5% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | -2.2% |
-13.4% |
-23.2% |
SENSEX | 0.5% |
4.2% |
8% |
You may also like the below Video Courses